PortfoliosLab logo

BiondVax Pharmaceuticals Ltd. (BVXV)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS09073Q1058
CUSIP09073Q105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.22
Year Range$1.15 - $3.44
EMA (50)$1.31
EMA (200)$1.77
Average Volume$64.99K
Market Capitalization$22.77M

BVXVShare Price Chart


Chart placeholderClick Calculate to get results

BVXVPerformance

The chart shows the growth of $10,000 invested in BiondVax Pharmaceuticals Ltd. on May 13, 2015 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,064 for a total return of roughly -69.36%. All prices are adjusted for splits and dividends.


BVXV (BiondVax Pharmaceuticals Ltd.)
Benchmark (^GSPC)

BVXVReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-5.95%-6.21%
YTD-47.97%-18.17%
6M-56.02%-17.47%
1Y-58.27%-8.89%
5Y-32.36%10.75%
10Y-15.94%9.61%

BVXVMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BVXVSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BiondVax Pharmaceuticals Ltd. Sharpe ratio is -0.46. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BVXV (BiondVax Pharmaceuticals Ltd.)
Benchmark (^GSPC)

BVXVDividend History


BiondVax Pharmaceuticals Ltd. doesn't pay dividends

BVXVDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BVXV (BiondVax Pharmaceuticals Ltd.)
Benchmark (^GSPC)

BVXVWorst Drawdowns

The table below shows the maximum drawdowns of the BiondVax Pharmaceuticals Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BiondVax Pharmaceuticals Ltd. is 97.75%, recorded on Feb 23, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.75%Jul 14, 2020408Feb 23, 2022
-61.86%Jul 25, 2017357Dec 24, 2018259Jan 13, 2020616
-53.99%Jan 30, 202032Mar 16, 202031Apr 29, 202063
-39.76%Jun 29, 2015294Nov 23, 201645Feb 9, 2017339
-26.79%May 22, 202014Jun 11, 20208Jun 23, 202022
-15.54%Apr 5, 201712Apr 21, 201716May 15, 201728
-15.48%May 16, 201713Jun 5, 201710Jun 19, 201723
-13.9%Jun 27, 201712Jul 13, 20173Jul 18, 201715
-13.48%Mar 3, 201715Mar 24, 20174Mar 30, 201719
-13.12%Jan 14, 20203Jan 16, 20204Jan 23, 20207

BVXVVolatility Chart

Current BiondVax Pharmaceuticals Ltd. volatility is 38.30%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BVXV (BiondVax Pharmaceuticals Ltd.)
Benchmark (^GSPC)

Portfolios with BiondVax Pharmaceuticals Ltd.


Loading data...